MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
29.04
-2.93 (-9.16%)
At close: Apr 28, 2026, 4:00 PM EDT
29.30
+0.26 (0.90%)
After-hours: Apr 28, 2026, 5:35 PM EDT

MBX Biosciences Stock Forecast

Stock Price Forecast

The 9 analysts with 12-month price forecasts for MBX Biosciences stock have an average target of 56, with a low estimate of 18 and a high estimate of 88. The average target predicts an increase of 92.84% from the current stock price of 29.04.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $18 $56 $56 $88
Change -38.02% +92.84% +92.84% +203.03%
* Price targets were last updated on Jan 28, 2026.

Analyst Ratings

The average analyst rating for MBX Biosciences stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Nov '25Dec '25Jan '26Feb '26Mar '26Apr '26
Strong Buy 456666
Buy 334443
Hold 000000
Sell 000000
Strong Sell 011111
Total 7911111110

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Barclays
Barclays
Buy
Initiates
$66
Buy Initiates $66 +127.27% Jan 28, 2026
Guggenheim
Guggenheim
Strong Buy
Maintains
$77$88
Strong Buy Maintains $77$88 +203.03% Jan 16, 2026
UBS
UBS
Strong Buy
Initiates
$60
Strong Buy Initiates $60 +106.61% Jan 7, 2026
Stifel
Stifel
Strong Buy
Maintains
$45$50
Strong Buy Maintains $45$50 +72.18% Dec 19, 2025
Goldman Sachs
Goldman Sachs
Strong Sell
Initiates
$18
Strong Sell Initiates $18 -38.02% Dec 4, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.96
from -2.38
EPS Next Year
-4.12
from -2.96
Fiscal Year FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027 FY 2028
Period Ending Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027 Dec 31, 2028
Revenue
------4.81M
Revenue Growth
-------
EPS
-39.18-31.96-5.82-2.38-2.96-4.12-4.36
EPS Growth
-------
Forward PE
-------
No. Analysts ----131310
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20262027202820292030203120322033
High n/a n/a
Avg n/a n/a
Low n/a n/a

Revenue Growth

Revenue Growth 20262027202820292030203120322033
High - -
Avg - -
Low - -

EPS Forecast

EPS 20262027202820292030203120322033
High -2.71 -3.24
Avg -2.96 -4.12
Low -3.15 -6.88

EPS Growth

EPS Growth 20262027202820292030203120322033
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.